U.S. health experts this week will decide whether to recommend approval for Biogen Inc.’s experimental Alzheimer’s drug, which could become the first new treatment for the mind-wasting disease in decades even as serious questions persist over whether data show if the antibody aducanumab works.
The Consistent Testing Terminology Working Group published a white paper with industry-wide recommendations for precision medicine testing terms to be utilized in patient education and communication.
Healthline Media and the National Alliance on Mental Illness announced the winners of the Healthline Stronger Scholarship, which is awarded to four university students around the U.S. for their commitment to academic and professional pursuits in mental health.
Shire, Microsoft and EURORDIS-Rare Diseases Europe announced a strategic alliance to address the diagnostic challenge for patients living with a rare disease.